Sanofi Scheduled to Report Q3 2026 Earnings on October 30
Sanofi (SNY) is set to release its third-quarter 2026 financial results on Friday, October 30, prior to the market opening. Market analysts have established a consensus earnings per share (EPS) estimate of $1.51, which represents a significant year-over-year decline of 34.3%. Despite the projected drop in profitability, revenue expectations remain strong with a consensus estimate of $14.83 billion, marking a 19.3% increase compared to the same period last year. Investors will be closely monitoring these results to reconcile the divergence between rising top-line growth and declining bottom-line earnings.
Tickers: $SNY
Topics: earnings_announcement eps_estimates revenue_forecast